Description

3-Bromo-6-Fluoro-5-Methoxy-2H-Benzo[E][1,2,4]Thiadiazine 1,1-Dioxide is a high-purity, advanced pharmaceutical intermediate characterized by its unique heterocyclic structure containing bromo, fluoro, and methoxy substituents. This compound is of significant value for medicinal chemistry research and development, serving as a critical building block for the synthesis of novel bioactive molecules. It is primarily sought after by research institutions and pharmaceutical companies engaged in the development of new therapeutic agents, particularly in areas requiring sophisticated chemical scaffolds.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders, oncology, and anti-inflammatory pathways.
• Medicinal Chemistry Research: Used extensively in structure-activity relationship (SAR) studies and lead optimization programs due to its versatile and modifiable chemical structure.
• Active Pharmaceutical Ingredient (API) Development: Serves as a core scaffold in the development of new chemical entities (NCEs) and potential APIs.
• Chemical Biology Probes: Utilized in the design and synthesis of chemical probes for investigating biological targets and pathways in academic and industrial research.
• Agrochemical Research: Potential application as an intermediate in the development of new herbicides or fungicides, leveraging its heterocyclic core.
• Material Science: Exploration of its use in the synthesis of specialty polymers or organic electronic materials due to its electron-deficient aromatic system.

Basic Information

Product Name	3-Bromo-6-Fluoro-5-Methoxy-2H-Benzo[E][1,2,4]Thiadiazine 1,1-Dioxide
CAS No.	2100839-49-2
Molecular Formula	C8H5BrFN3O3S
Molecular Weight	322.11 g/mol
Synonyms	3-Bromo-6-fluoro-5-methoxy-2H-1,2,4-benzothiadiazine 1,1-dioxide; 3-Bromo-6-fluoro-5-methoxy-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide; Benzo[e][1,2,4]thiadiazine, 3-bromo-6-fluoro-5-methoxy-2H-, 1,1-dioxide; 2100839-49-2; 3-Br-6-F-5-MeO-2H-benzo[E][1,2,4]thiadiazine dioxide
EINECS	Contact for details

Quality Control

Our production of 3-Bromo-6-Fluoro-5-Methoxy-2H-Benzo[E][1,2,4]Thiadiazine 1,1-Dioxide adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. Each lot undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry. Certificates of Analysis (COA) detailing all specifications are provided with every shipment. We support development and cGMP-grade production to meet the rigorous standards of pharmaceutical R&D and manufacturing.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture. Store away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (NMR)	Conforms
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.